64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending
included in some trendy products but not widely used yet
Dietary supplements marketed as glp 1 booster products do not contain synthetic GLP-1 hormones
It was very loosey goosy as to how you get the drug
Before starting GLP-1 medication, our medical team will evaluate your health, lifestyle, and metabolic profile
FDA approves Ozempic (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [press release]